CStone Pharmaceuticals Email Format
Pharmaceutical ManufacturingShanghai, China51-200 Employees
CStone Pharmaceuticals is a biopharmaceutical company based in Shanghai's Pudong district, focused on developing therapies for oncology, immunology, inflammation, and other key disease areas. Founded in late 2015, it aims to address unmet medical needs in China and globally. The company has brought four novel drugs to market and secured approvals for 21 new drug applications across nine indications, while maintaining a pipeline of about 16 candidates. Its portfolio spans antibody-drug conjugates, multispecific antibodies, immunotherapies, and precision medicines. In January 2025, CStone announced a strategic commercialization partnership with SteinCares to gain rights to market sugemalimab in ten Latin American countries.
1-888-653-2347 
support@leadiq.com 
